ArianeGroup has successfully carried out the first ignition campaign of the reusable Prometheus® engine on the reusable Themis rocket core stage demonstrator – a key step in providing Europe with the ...
SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces a new Anser ® therapeutic drug monitoring (TDM) test for ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...
Saliva-based diagnostic detects genes related to the disease and calculates risk. Prometheus has selected DNA Genotek’s Oragene®•DNA product as the sample-collection kit for MyCeliacID™, a ...
WASHINGTON (AP) – The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories on Tuesday for a test that could help doctors set drug doses for autoimmune diseases like ...
Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal Assessment as MASH Therapies Expand Prometheus has been at the forefront ...
Prometheus Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease
SAN DIEGO, Aug. 31 Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This ...
Prometheus Laboratories announced the launch of its monitoring test, PROMETHEUS Anser IFX, which measures infliximab (Remicade; Janssen Biotech) and infliximab antibody levels in one sample to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results